Female sexual dysfunction in essential hypertension: A common problem being uncovered

Journal of Hypertension

Volumn 24, Issue 12, 2006, Pages 2387-2392

  Doumas, Michael ^a,b   Tsiodras, Sotirios ^a   Tsakiris, Alexandros ^a   Douma, Stella ^a   Chounta, Athina ^a   Papadopoulos, Angelos ^a   Kanellakopoulou, Kiriaki ^a   Giamarellou, Helen ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Female sexual dysfunction; Female Sexual Function Index; Hypertension; Hypertension control; Hypertension treatment; Sexual function; blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE COURSE; ESSENTIAL HYPERTENSION; EVALUATION; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL;

EID: 33750584533     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000251898.40002.5b     Document Type: Article

References (28)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States; prevalence and predictors. JAMA 1999; 281:537-544.
2. Read S, King M, Watson J. Sexual dysfunction in primary medical care: prevalence, characteristics and detection by the general practitioner. J Public Health Med 1997; 19:387-391.
3. Doumas M, Douma S. Sexual dysfunction in essential hypertension: myth or reality? J Clin Hypertens 2006; 8:269-274.
4. Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared to normotensive subjects. J Androl 2006; 27:469-477.
5. Martin-Morales A, Sanchez-Cruz JJ, Saenz de Tejada I, Rodriguez-Vela L, Jimenez-Cruz JF, Burgos-Rodriguez R. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfunction Erectil Masculina Study. J Urol 2001; 166:569-575.
6. Grimm R, Grandits G, Prineas R, McDonald R, Lewis C, Flack J, et al. Long term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women: Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29:8-14.
7. Lewis C, Duncan LE, Balance DI, Pearson TA. Is sexual dysfunction in hypertensive women uncommon or understudied? Am J Hypertens 1998; 11:733-735.
8. Duncan LE, Lewis C, Jenkins P, Pearson TA. Does hypertension and its pharmacotherapy affect the quality of sexual function in women? Am J Hypertens 2000; 13:640-647.
9. Meston CM, Derogatis LR. Validated instruments for assessing female sexual function. J Sex Marital Ther 2002; 28 (Suppl 1):155-164.
10. Lightner DJ. Female sexual dysfunction. Mayo Clin Proc 2002; 77:698-702.
11. Rosen RC, Brown C, Heiman J, Leiblum S, Meston CM, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26:191-208.
12. Meston CM. Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder. J Sex Marital Ther 2003; 29:39-46.
13. Wiegel M, Meston C, Rosen R. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005; 31:1-20.
14. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42:1206-1252.
15. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21:1011-1053.
16. Duncan L, Bateman DN. Sexual function in women: do antihypertensive drugs have an impact? Drug Saf 1993; 8:225-234.
17. Prisant CM, Carr AA, Botlini PB. Sexual dysfunction with antihypertensive drugs. Arch Int Med 1994; 154:730-736.
18. Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female sexual dysfunction in a healthy Austrian cohort: prevalence and risk factors. Eur Urol 2005; 47:366-375.
19. Goldstein I, Berman JR. Vasculogenic female sexual dysfunction: vaginal engorgement and clitoral erectile insufficiency syndrome. Int J Impot Res 1998; 10:S84-S90.
20. Tarkan T, Park K, Goldstein I. Histomorphometric analysis of age-related structural changes in human clitoral cavernosal tissue. J Urol 1999; 161:940-944.
21. Berman JR, Adhikari SP, Goldstein I. Anatomy and physiology of female sexual function and dysfunction: classification, evaluation and treatment options. Eur Urol 2000; 38:20-29.
22. Munarriz R, Kim SW, Kim NN, Traish A, Goldstein I. A review of the physiology and pharmacology of peripheral (vaginal and clitoral) female genital arousal in the animal model. J Urol 2003; 170:S40-S45.
23. Doumas M, Tsakiris A, Douma S, Hounta A, Papadopoulos A, Tsiodras S, Giamarellou E. Beneficial effects of switching b-blockers to nebivolol on erectile function. Asian J Androl 2006; 8:177-182.
24. Doumas M, Douma S. The effect of antihypertensive drugs on erectile function. A proposed management algorithm. J Clin Hypertens 2006; 8:359-364.
25. Addis IB, Ireland CC, Vittinghoff E, Lin F, Stuenkel CA, Hulley S. Sexual activity and function in postmenopausal women with heart disease. Obstet Gynecol 2005; 106:121-127.
26. Fogari R, Preti P, Zoppi A, Corradi L, Pasotti C, Rinaldi A, et al. Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women. Am J Hypertens 2004; 17:77-81.
27. Cayan S, Akbay E, Bozlu M, Canpolat B, Acar D, Ulusoy E. The prevalence of female sexual dysfunction and potential risk factors that may impair sexual function in Turkish women. Urol Int 2004; 72:52-57.
28. Castelo-Branco C, Blumel JF, Araya H, Riquelme R, Castro G, Haya J. Prevalence of sexual dysfunction in a cohort of middle-aged women: influences of menopause and hormone replacement therapy. J Obstet Gynaecol 2003; 23:426-430.